Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative superior mesenteric artery stenting following pancreaticoduodenectomy in a patient with severe mesenteric atherosclerosis.

Journal of surgical case reports·2026
Same author

Creative pancreatectomy provides durable therapy for chronic pancreatitis.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2025
Same author

Distal pancreatectomy for chronic pancreatitis: The influence of body mass index.

Surgery·2025
Same author

Contemporary Outcomes of Pancreatic Head Resection for Chronic Pancreatitis.

Annals of surgery·2025
Same author

Contemporary Outcomes of Transduodenal Sphincteroplasty: the Importance of Surgical Quality.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2023
Same author

Do Weekend Discharges Impact Readmission Rate in Patients Undergoing Pancreatic Surgery?

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2023
Same journal

Cardiotoxicity, survival, and dexrazoxane use in patients with soft tissue sarcoma: a Danish population‑based cohort study.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Overall survival following palliative immune checkpoint inhibitor treatment according to ECOG performance status: a large registry-based study.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Recent survival trends in the most fatal cancers in the Nordic countries: gains in some but not in all.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

First-in-human quantitative [¹⁵O]H₂O PET imaging of tumour blood flow at rest and during exercise in lymphoma patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Starshot field configuration in the linac isocentre size determination: a comparison of film and electronic portal imaging device measurements.

Acta oncologica (Stockholm, Sweden)·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Pancreatic cancer: progress made.

Vlad V Simianu1, Nicholas J Zyromski, Attila Nakeeb

  • 1Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Acta Oncologica (Stockholm, Sweden)
|January 12, 2010
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer surgery offers the only cure but has a poor long-term outlook. Advances in diagnosis and multimodality treatments are crucial for improving survival rates in pancreatic cancer patients.

More Related Videos

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

Related Experiment Videos

Last Updated: Jun 17, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Pancreatic cancer is a significant cause of cancer mortality, with surgeons playing a critical role in its diagnosis and management.
  • Current preoperative staging relies heavily on pancreas-protocol abdominal CT, with endoscopic ultrasound and diagnostic laparoscopy offering supplementary value.
  • Surgical resection is the sole curative treatment, achieving low perioperative mortality (<3%) in high-volume centers, though complications persist.

Discussion:

  • Despite surgical advances, long-term prognosis for pancreatic cancer remains poor, evidenced by 5-year survival rates of 15-23% and median survival of 13-18 months.
  • Recent clinical trials suggest adjuvant chemotherapy is beneficial, while the role of traditional radiation therapy is being re-evaluated.
  • Optimizing outcomes necessitates early diagnosis and comprehensive, multimodality treatment strategies.

Key Insights:

  • The critical role of surgeons in pancreatic cancer management, from diagnosis to resection.
  • The limitations of current treatments, highlighting the need for improved long-term survival strategies.
  • The evolving landscape of adjuvant therapies, with a shift towards chemotherapy and a re-evaluation of radiation.

Outlook:

  • Future efforts must focus on enhancing early detection methods for pancreatic cancer.
  • Developing targeted multimodality treatment plans is essential for improving patient survival.
  • Continued research into novel therapeutic approaches is vital to overcome the challenges posed by pancreatic cancer.